These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3043658)

  • 1. Metabolic reduction of chromium as a threshold mechanism limiting its in vivo activity.
    Petrilli FL; de Flora S
    Sci Total Environ; 1988 Jun; 71(3):357-64. PubMed ID: 3043658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic reduction of chromium, as related to its carcinogenic properties.
    De Flora S; Serra D; Camoirano A; Zanacchi P
    Biol Trace Elem Res; 1989; 21():179-87. PubMed ID: 2484584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prominent role of DT-diaphorase as a cellular mechanism reducing chromium(VI) and reverting its mutagenicity.
    De Flora S; Morelli A; Basso C; Romano M; Serra D; De Flora A
    Cancer Res; 1985 Jul; 45(7):3188-96. PubMed ID: 4005852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimates of the chromium(VI) reducing capacity in human body compartments as a mechanism for attenuating its potential toxicity and carcinogenicity.
    De Flora S; Camoirano A; Bagnasco M; Bennicelli C; Corbett GE; Kerger BD
    Carcinogenesis; 1997 Mar; 18(3):531-7. PubMed ID: 9067553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of chromium(VI) to chromium(V) by rat liver cytosolic and microsomal fractions: is DT-diaphorase involved?
    Aiyar J; De Flora S; Wetterhahn KE
    Carcinogenesis; 1992 Jul; 13(7):1159-66. PubMed ID: 1379126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic reduction of chromium by alveolar macrophages and its relationships to cigarette smoke.
    Petrilli FL; Rossi GA; Camoirano A; Romano M; Serra D; Bennicelli C; De Flora A; De Flora S
    J Clin Invest; 1986 Jun; 77(6):1917-24. PubMed ID: 2423559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Threshold mechanisms and site specificity in chromium(VI) carcinogenesis.
    De Flora S
    Carcinogenesis; 2000 Apr; 21(4):533-41. PubMed ID: 10753182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity and inducibility of the metabolic reduction of chromium(VI) mutagenicity by subcellular fractions of rat tissues.
    Petrilli FL; Camoirano A; Bennicelli C; Zanacchi P; Astengo M; De Flora S
    Cancer Res; 1985 Jul; 45(7):3179-87. PubMed ID: 4005851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reductive metabolism and protein binding of chromium(VI) by P450 protein enzymes.
    Mikalsen A; Alexander J; Wallin H; Ingelman-Sundberg M; Andersen RA
    Carcinogenesis; 1991 May; 12(5):825-31. PubMed ID: 1903091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hexavalent chrome: threshold concept for carcinogenicity.
    Jones RE
    Biomed Environ Sci; 1990 Mar; 3(1):20-34. PubMed ID: 2184841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of hexavalent chromium resistance and removal by microorganisms.
    Joutey NT; Sayel H; Bahafid W; El Ghachtouli N
    Rev Environ Contam Toxicol; 2015; 233():45-69. PubMed ID: 25367133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron stimulates the rate of reduction of hexavalent chromium by human microsomes.
    Myers CR; Myers JM
    Carcinogenesis; 1998 Jun; 19(6):1029-38. PubMed ID: 9667741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of hexavalent chromium by fasted and fed human gastric fluid. I. Chemical reduction and mitigation of mutagenicity.
    De Flora S; Camoirano A; Micale RT; La Maestra S; Savarino V; Zentilin P; Marabotto E; Suh M; Proctor DM
    Toxicol Appl Pharmacol; 2016 Sep; 306():113-9. PubMed ID: 27404458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo effects of ascorbate and glutathione on the uptake of chromium, formation of chromium(V), chromium-DNA binding and 8-hydroxy-2'-deoxyguanosine in liver and kidney of osteogenic disorder shionogi rats following treatment with chromium(VI).
    Yuann JM; Liu KJ; Hamilton JW; Wetterhahn KE
    Carcinogenesis; 1999 Jul; 20(7):1267-75. PubMed ID: 10383900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human ingestion of chromium (VI) in drinking water: pharmacokinetics following repeated exposure.
    Finley BL; Kerger BD; Katona MW; Gargas ML; Corbett GC; Paustenbach DJ
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):151-9. PubMed ID: 9007044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A revised model of ex-vivo reduction of hexavalent chromium in human and rodent gastric juices.
    Schlosser PM; Sasso AF
    Toxicol Appl Pharmacol; 2014 Oct; 280(2):352-61. PubMed ID: 25151221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of hexavalent chromium by mitochondria: methodological implications and possible mechanisms.
    Arillo A; Melodia F; Frache R
    Ecotoxicol Environ Saf; 1987 Oct; 14(2):164-77. PubMed ID: 3691371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of hexavalent chromium by ascorbic acid in rat lung lavage fluid.
    Suzuki Y
    Arch Toxicol; 1988; 62(2-3):116-22. PubMed ID: 3196146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis in the lung but not in the liver of rats receiving intra-tracheal instillations of chromium(VI).
    D'Agostini F; Izzotti A; Bennicelli C; Camoirano A; Tampa E; De Flora S
    Carcinogenesis; 2002 Apr; 23(4):587-93. PubMed ID: 11960910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacokinetic model for chromium.
    O'Flaherty EJ
    Toxicol Lett; 1993 May; 68(1-2):145-58. PubMed ID: 8516761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.